Permeability and Residual Plasma Volume of Human, Dutch Variant, and Rat Amyloid β-Protein 1-40 at the Blood–Brain Barrier
Tài liệu tham khảo
Biere, 1996, Amyloid β-peptide (Aβ) is transported on lipoproteins and albumin in human plasma, J. Biol. Chem., 271, 32916, 10.1074/jbc.271.51.32916
Clemens, 1992, Implants containing β-amyloid protein are not neurotoxic to young and old rat brain, Neurobiol. Aging, 13, 581, 10.1016/0197-4580(92)90059-7
Emre, 1992, The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brain, Neurobiol. Aging, 13, 553, 10.1016/0197-4580(92)90055-3
Games, 1992, Lack of Alzheimer pathology after β-amyloid protein injections in rat brain, Neurobiol. Aging, 13, 569, 10.1016/0197-4580(92)90057-5
Haan, 1990, Hereditary cerebral hemorrhage with amyloidosis-Dutch type. Clinical and computed tomographic analysis of 24 cases, Arch. Neurol., 47, 649, 10.1001/archneur.1990.00530060059018
Kowall, 1991, An in vivo model for the neurodegenerative effects of beta-amyloid and protection by substance-P, Proc. Natl. Acad. Sci. USA, 88, 7247, 10.1073/pnas.88.16.7247
Kowall, 1992, In vivo neurotoxicity of β-amyloid [β(1-40)] and the β(25-35) fragment, Neurobiol. Aging, 13, 537, 10.1016/0197-4580(92)90053-Z
Levy, 1990, Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type, Science, 248, 1124, 10.1126/science.2111584
Luyendijk, 1988, Hereditary cerebral haemorrhage caused by cortical amyloid angiopathy, J. Neurol. Sci., 85, 267, 10.1016/0022-510X(88)90186-4
Maness, 1994, Passage of human amyloid β-protein 1-40 across the murine blood–brain barrier, Life Sci., 55, 1643, 10.1016/0024-3205(94)00331-9
Martel, 1996, Blood–brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs, Neurosci. Lett., 206, 157, 10.1016/S0304-3940(96)12462-9
Ohno, 1978, Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat, Am. J. Physiol., 235, H299
Podlisny, 1993, Microinjection of synthetic amyloid β-protein in monkey cerebral cortex fails to produce acute neurotoxicity, Am. J. Pathol., 142, 17
Poduslo, 1982, Altered blood nerve barrier in experimental lead neuropathy assessed by changes in endoneurial albumin concentration, J. Neurosci., 2, 1507, 10.1523/JNEUROSCI.02-10-01507.1982
Poduslo, 1988, Increase in albumin, IgG, and IgM blood–nerve barrier indices in human diabetic neuropathy, Proc. Natl. Acad. Sci. USA, 85, 4879, 10.1073/pnas.85.13.4879
Poduslo, 1993, Albumin and the blood–nerve barrier
Poduslo, 1994, Macromolecular permeability across the blood–nerve and blood–brain barriers, Proc. Natl. Acad. Sci. USA, 91, 5705, 10.1073/pnas.91.12.5705
Poduslo, 1992, Increased permeability across the blood–nerve barrier of albumin glycatedin vitroin vivo, Proc. Natl. Acad. Sci. USA, 89, 2218, 10.1073/pnas.89.6.2218
Poduslo, 1994, Glycation increases in permeability of proteins across the blood–nerve and blood–brain barriers, Molec. Brain Res., 23, 157, 10.1016/0169-328X(94)90222-4
Poduslo, 1996, Polyamine modification increases the permeability of proteins at the blood–nerve and blood–brain barriers, J. Neurochem., 66, 1599, 10.1046/j.1471-4159.1996.66041599.x
Poduslo, 1996, Permeabilities at the blood–brain and blood–nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF, Mol. Brain Res., 36, 280, 10.1016/0169-328X(95)00250-V
Poduslo, 1980, Molecular weight estimation using sodium dodecyl sulfate-pore gradient electrophoresis, Anal. Biochem., 101, 394, 10.1016/0003-2697(80)90205-5
Rush, 1992, Intracerebral β-amyloid(25-35) produces tissue damage: Is it neurotoxic?, Neurobiol. Aging, 13, 591, 10.1016/0197-4580(92)90061-2
Saito, 1995, Vector-mediated delivery of1251-401-40, Proc. Natl. Acad. Sci. USA, 92, 10227, 10.1073/pnas.92.22.10227
Smith, 1985, Measurement of protein using bicinchoninic acid, Anal. Biochem., 150, 76, 10.1016/0003-2697(85)90442-7
Smyth, 1994, Analysis of brain injury following intrahippocampal administration of beta-amyloid in streptozotocin-treated rats, Neurobiol. Aging, 15, 153, 10.1016/0197-4580(94)90106-6
Snow, 1994, An important role of heparin sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar Aβ-amyloid in rat brain, Neuron, 12, 219, 10.1016/0896-6273(94)90165-1
Stein-Behrens, 1992, Failure of β-amyloid protein fragment 25-35 to cause hippocampal damage in the rat, Neurobiol. Aging, 13, 577, 10.1016/0197-4580(92)90058-6
Stephenson, 1992, In vivo effects of β-amyloid implants in rodents: Lack of potentiation of damage associated with transient global forebrain ischemia, Brain Res., 586, 235, 10.1016/0006-8993(92)91632-O
Van Broeckhoven, 1990, Amyloid β protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch), Science, 248, 1120, 10.1126/science.1971458
van Duinen, 1987, Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease, Proc. Natl. Acad. Sci. USA, 84, 5991, 10.1073/pnas.84.16.5991
Waite, 1992, Solvent effects on beta protein toxicity in vivo, Neurobiol. Aging, 13, 595, 10.1016/0197-4580(92)90062-3
Wang, 1994, Hippocampal β-amyloid reduces locus coeruleus glutamate and tyrosine hydroxylase, Brain Res. Bull., 35, 485, 10.1016/0361-9230(94)90162-7
Wattendorff, 1995, Hereditary cerebral haemorrhage with amyloidosis, Dutch type (HCHWA-D): Clinicopathological studies, J. Neurol. Neurosurg. Psychiatry, 58, 699, 10.1136/jnnp.58.6.699
Winkler, 1994, Lack of long-term effects after β-amyloid protein injections in rat brain, Neurobiol. Aging, 15, 601, 10.1016/0197-4580(94)00054-9
Zlokovic, 1993, Blood–brain barrier transport of circulating Alzheimer's amyloid β, Biochem. Biophys. Res. Commun., 197, 1034, 10.1006/bbrc.1993.2582
Zlokovic, 1994, Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid β, Biochem. Biophys. Res. Commun., 205, 1431, 10.1006/bbrc.1994.2825
Zlokovic, 1996, Glycoprotein 330/megalin: Probable role in receptor-mediated transport of apolipoprotein j alone and in a complex with Alzheimer disease amyloid beta at the blood–brain and blood–cerebrospinal fluid barriers, Proc. Natl. Acad. Sci. USA, 93, 4229, 10.1073/pnas.93.9.4229